Updated Jul 16, 2026
Burnam Bradley Evan has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Burnam Bradley Evan is the Chief Executive Officer of Turn Therapeutics Inc., a company focused on developing innovative therapeutic solutions. Further details about his career and achievements are not widely documented in public sources.
| Role | Chief Executive Officer, Director, 10% Owner |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-01 | TTRX | Turn Therapeutics Inc. | G — Bona-fide gift | 300.0K | $0.00 | |
| 2026-06-01 | TTRX | Turn Therapeutics Inc. | G — Bona-fide gift | 300.0K | $0.00 | |
| 2026-06-01 | TTRX | Turn Therapeutics Inc. | G — Bona-fide gift | 300.0K | $0.00 | |
| 2026-06-01 | TTRX | Turn Therapeutics Inc. | G — Bona-fide gift | 300.0K | $0.00 | |
| 2026-04-03 | TTRX | Turn Therapeutics Inc. | G — Bona-fide gift | 300.0K | $0.00 |
Burnam Bradley Evan is the Chief Executive Officer of Turn Therapeutics Inc., a company focused on developing innovative therapeutic solutions. Further details about his career and achievements are not widely documented in public sources.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Burnam Bradley Evan profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.